Biosimilar Drugs
-
{
- All
- News
- Videos
-
From Pharmacy Of World To Innovation Hub: PM Modi Bats For India's Pharmaceutical Leap
New Delhi, April 14 (IANS) Prime Minister Narendra Modi on Tuesday said that India’s pharma sector is moving up from the pharmacy of the world to a hub of innovation.
-
India To Lead Global Pharma Landscape With Innovation-Driven Approach: Minister
India aims to lead global pharma with focus on biologics, biosimilars, and specialty medicines, says Health Minister JP Nadda.
-
India Pharmaceutical Sector Aims To Make India A Global Innovation Hub In 2026
New Delhi, March 30 (IANS) India’s pharmaceutical sector is set to take a major step towards becoming an innovation-driven global powerhouse, as India Pharma 2026 aims to accelerate the industry’s transition from volume-based growth to value and rese
-
US Proposal Could Halve Biocon's Biosimilar Development Costs
India's Biocon expects a 50% drop in costs for developing complex biosimilars as the United States has proposed to ease clinical testing for the drugs that make up more than 60% of its revenue, a top executive said on Wednesday.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
From Pharmacy Of World To Innovation Hub: PM Modi Bats For India's Pharmaceutical Leap
New Delhi, April 14 (IANS) Prime Minister Narendra Modi on Tuesday said that India’s pharma sector is moving up from the pharmacy of the world to a hub of innovation.
-
India To Lead Global Pharma Landscape With Innovation-Driven Approach: Minister
India aims to lead global pharma with focus on biologics, biosimilars, and specialty medicines, says Health Minister JP Nadda.
-
India Pharmaceutical Sector Aims To Make India A Global Innovation Hub In 2026
New Delhi, March 30 (IANS) India’s pharmaceutical sector is set to take a major step towards becoming an innovation-driven global powerhouse, as India Pharma 2026 aims to accelerate the industry’s transition from volume-based growth to value and rese
-
US Proposal Could Halve Biocon's Biosimilar Development Costs
India's Biocon expects a 50% drop in costs for developing complex biosimilars as the United States has proposed to ease clinical testing for the drugs that make up more than 60% of its revenue, a top executive said on Wednesday.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
